Sequoia Financial Advisors LLC Takes $345,000 Position in Acadia Healthcare Company, Inc. $ACHC

Sequoia Financial Advisors LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,742 shares of the company’s stock, valued at approximately $345,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Aberdeen Group plc increased its stake in Acadia Healthcare by 72.3% in the fourth quarter. Aberdeen Group plc now owns 743,925 shares of the company’s stock valued at $10,556,000 after purchasing an additional 312,172 shares during the period. Louisiana State Employees Retirement System purchased a new stake in shares of Acadia Healthcare in the first quarter valued at about $957,000. SG Americas Securities LLC increased its stake in shares of Acadia Healthcare by 717.8% during the fourth quarter. SG Americas Securities LLC now owns 292,425 shares of the company’s stock worth $4,150,000 after acquiring an additional 256,669 shares during the period. Prescott Group Capital Management L.L.C. purchased a new position in Acadia Healthcare during the fourth quarter worth about $2,838,000. Finally, FourThought Financial Partners LLC acquired a new stake in Acadia Healthcare in the fourth quarter valued at about $325,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $34.78 on Thursday. The stock has a fifty day moving average price of $27.32 and a 200 day moving average price of $22.96. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The stock has a market cap of $3.20 billion, a PE ratio of -2.84, a P/E/G ratio of 11.88 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.Acadia Healthcare’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on ACHC shares. Barclays boosted their target price on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 30th. Cantor Fitzgerald upped their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. UBS Group increased their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Royal Bank Of Canada boosted their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Finally, TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $28.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.